ArticleIndian journal of clinical biochemistry : IJCB2025
miR-335-5p Inhibits EMT and PI3K/AKT Pathways via MARCH8.
Article in Indian journal of clinical biochemistry : IJCB, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Ubiquitination is a highly conserved process that regulates protein stability by post-translational modification. Membrane-associated RING-CH (MARCH) proteins belong to a family of transmembrane E3 ligases which are responsible for the degradation of their target proteins. Recently, several MARCH family members, including MARCH8, have been reported to be deregulated in cancers. However, the nuances of the exact mechanism remain unexplored. Herein, we investigated regulation of PI3K/AKT and EMT pathways in esophageal cancer via miR-335-5p/MARCH8 axis. Putative miRNAs regulating MARCH8 expression were predicted using in-silico tools. Correlation between expression of miR-335-5p and MARCH8 in esophageal cancer and distant matched non-malignant tissues was evaluated using Real-time PCR. Further, luciferase assay and western blot analysis were carried out to study the direct regulation of MARCH8 via miR-335-5p in esophageal cancer cells. Expression of MARCH8 and miR-335-5p was modulated in esophageal cancer cells and its effect on PI3K/AKT and EMT pathways was evaluated using western blot analysis. Prediction tools revealed miR-335-5p to be the most promising miRNA that might regulate MARCH8 expression. Next, expression analysis of miR-335-5p and MARCH8 in esophageal cancer and distant matched non-malignant tissues revealed an inverse correlation between miR-335-5p and MARCH8 expression (
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.